Home
President's Message
Chief Academic Officer's Message
Scientific & Medical Research Departments
M. D. Anderson Research News
Reports Organized by:
Researcher Name
Department
Research Center & Program
Care Center
Related Documents:
Clinical Trials
Awards
Standard Abbreviations
Disclaimer of Liability
Copyright, Contact Information, & Credits
For M. D. Anderson Staff Only:
Preparing a Research Report
Create New Research Report
Create New Division/Department Overview
Create New Faculty List
|  |
| Emil J Freireich, DSc (Hon), MD
Research Interests:
Biology and natural history of and therapy for human leukemia |
My research focuses on studying the natural history of leukemia and evaluating therapies for the disease. I interact closely with my colleagues in the Department of Leukemia. I also collaborate with the Department of Hematopathology and faculty in the Department of Laboratory Medicine in assessing clinical pathologic findings of leukemia and studying leukocyte transfusion therapy for severe antibiotic resistant infection.
As Director of Special Medical Education Programs, I organize and supervise weekly Institutional Grand Rounds "Advances in Oncology," a weekly Core Curriculum course for all graduate medical trainees, and a Graduate Medical School curriculum for training in "Patient-Oriented Research," leading to M.S. and Ph.D. degrees.
Selected Publications
Freireich EJ, Kurzrock R, Estrov Z. Metastasis--an alternative hypothesis. Cancer 103:1537-1539, 2005
Freireich EJ. The investigational new drug application--who benefits? Nat Clin Pract Oncol 3:62-63, 2006
Freireich EJ. Should terminally ill patients have the right to take drugs that pass phase I testing? Yes. BMJ 335:478, 2007
Atallah E, Cortes J, O'Brien S, Pierce S, Rios MB, Estey E, Markman M, Keating M, Freireich EJ, Kantarjian H. Establishment of baseline toxicity expectations with standard frontline chemotherapy in acute myelogenous leukemia. Blood 110:3547-3551, 2007
Tsimberidou AM, Kantarjian HM, Wen S, O'Brien S, Cortes J, Wierda WG, Koller C, Pierce S, Brandt M, Freireich EJ, Keating MJ, Estey EH. The prognostic significance of serum beta2 microglobulin levels in acute myeloid leukemia and prognostic scores predicting survival: Analysis of 1,180 patients. Clin Cancer Res 14:721-730, 2008
Additional Information:
| Department: | Leukemia |
| Department URL: | |
| Division/Section: | Cancer Medicine |
| Last Updated: | 05/05/2008 |
|